1. Home
  2. ABCL vs BDN Comparison

ABCL vs BDN Comparison

Compare ABCL & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • BDN
  • Stock Information
  • Founded
  • ABCL 2012
  • BDN 1986
  • Country
  • ABCL Canada
  • BDN United States
  • Employees
  • ABCL N/A
  • BDN N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • BDN Real Estate Investment Trusts
  • Sector
  • ABCL Health Care
  • BDN Real Estate
  • Exchange
  • ABCL Nasdaq
  • BDN Nasdaq
  • Market Cap
  • ABCL 818.2M
  • BDN 799.6M
  • IPO Year
  • ABCL 2020
  • BDN N/A
  • Fundamental
  • Price
  • ABCL $2.42
  • BDN $3.78
  • Analyst Decision
  • ABCL Buy
  • BDN Hold
  • Analyst Count
  • ABCL 3
  • BDN 1
  • Target Price
  • ABCL $7.50
  • BDN $5.00
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • BDN 2.9M
  • Earning Date
  • ABCL 05-08-2025
  • BDN 04-22-2025
  • Dividend Yield
  • ABCL N/A
  • BDN 15.87%
  • EPS Growth
  • ABCL N/A
  • BDN N/A
  • EPS
  • ABCL N/A
  • BDN N/A
  • Revenue
  • ABCL $28,833,000.00
  • BDN $313,998,000.00
  • Revenue This Year
  • ABCL N/A
  • BDN $57.03
  • Revenue Next Year
  • ABCL $27.77
  • BDN $3.55
  • P/E Ratio
  • ABCL N/A
  • BDN N/A
  • Revenue Growth
  • ABCL N/A
  • BDN N/A
  • 52 Week Low
  • ABCL $1.89
  • BDN $3.41
  • 52 Week High
  • ABCL $4.34
  • BDN $6.54
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 52.58
  • BDN 35.39
  • Support Level
  • ABCL $1.89
  • BDN $3.41
  • Resistance Level
  • ABCL $2.53
  • BDN $3.84
  • Average True Range (ATR)
  • ABCL 0.19
  • BDN 0.23
  • MACD
  • ABCL 0.05
  • BDN -0.01
  • Stochastic Oscillator
  • ABCL 82.79
  • BDN 33.33

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About BDN Brandywine Realty Trust

Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.

Share on Social Networks: